Suchergebnisse - "Peterlin, Pierre"

PubPharm (16)

1

Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide

enthalten in: American journal of hematology | 2024

von Jullien, M. | Guillaume, T. | Le Bourgeois, A. | +19

2

Addition of ATG to non-myeloablative peripheral blood haploidentical transplant with PTCY decreases acute GVHD rates and improves GVHD-relapse free survival

enthalten in: Bone marrow transplantation | 2023

von Jullien, M. | Le Bourgeois, A. | Peterlin, P. | +4

3

Post-transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced-intensity conditioning allotransplant

enthalten in: Clinical and translational medicine | 2023

von Bourgeois, A. | Jullien, M. | Garnier, A. | +4

4

Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post-transplant cyclophosphamide

enthalten in: Cancer medicine | 2021

von Jullien, M. | Orvain, C. | Berceanu, A. | +18

5

Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis

enthalten in: Transplantation and cellular therapy | 2021

von Jullien, M. | Orvain, C. | Berceanu, A. | +18

6

Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide

enthalten in: Acta oncologica (Stockholm, Sweden) | 2021

von Chevallier, P. | Berceanu, A. | Peterlin, P. | +24

7

Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants : Comparison of T Cell and NK Effector Reconstitution

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2020

von Makanga, D. | Guillaume, T. | Willem, C. | +10

8

Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life

enthalten in: Annals of hematology | 2020

von Sortais, C. | Lok, A. | Tessoulin, B. | +15

9

Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide

enthalten in: Annals of hematology | 2020

von Garnier, A. | Guillaume, T. | Peterlin, P. | +14

10

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting : a single-center retrospective study

enthalten in: Annals of hematology | 2019

von Trudel, S. | Tessoulin, B. | Jullien, M. | +14